Humana (HUM)
NYSE:HUM
Want to see HUM full AI Analyst Report?
HUM Stock Chart & Stats
$205.14
$0.14(0.05%)
At close: 4:00 PM EST
$205.14
$0.14(0.05%)
Day’s Range― - ―
52-Week Range$163.11 - $379.50
Previous CloseN/A
Volume197.44K
Average Volume (3M)1.52M
Market Cap
$45.53B
Enterprise Value$45.71B
Total Cash (Recent Filing)$21.96B
Total Debt (Recent Filing)$13.99B
Price to Earnings (P/E)40.4
Beta0.86
Next Earnings
Jul 29, 2026EPS Estimate
7.23Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)9.38
Shares Outstanding120,061,500
10 Day Avg. Volume1,322,174
30 Day Avg. Volume1,518,802
Financial Highlights & Ratios
PEG Ratio-18.57
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue0.33
Enterprise Value/Gross Profit2.38
Enterprise Value/Ebitda16.03
Forecast
1Y Price Target
$292.33Price Target Upside42.50% Upside
Rating ConsensusHold
Number of Analyst Covering19
EPS Forecast (FY)8.83
Revenue Forecast (FY)$162.98B
Bulls Say, Bears Say
Bulls Say
Membership & Revenue GrowthSustained top-line growth and expanding membership across Medicare Advantage/Medicaid provide durable scale and risk-pooling benefits. Larger membership supports negotiating leverage, spreads fixed costs, and underpins long-term premium income even if margins fluctuate.
CenterWell Primary Care Expansion And M&ARapid CenterWell growth and accretive M&A increase Humana's vertically integrated care footprint, improving care coordination and potential to lower utilization. Owning primary care and pharmacy touchpoints supports durable cost management and member retention in value-based models.
Improved Liquidity And Contingent Funding OptionsPre-cap trusts and other liability management moves expand committed liquidity and optionality, reducing refinancing risk and smoothing capital planning. Enhanced funding structures support bid flexibility and reserve coverage while management pursues portfolio actions.
Bears Say
Compressed Profitability And Lower ReturnsSharp margin compression and lower ROE reduce the earnings cushion against underwriting and cost shocks. Persistently low margins constrain free cash flow, limit reinvestment and capital returns, and make meeting long-term margin targets more challenging.
Medical Cost Trends And Elevated ReservingStructural medical cost inflation above funding increases underwriting pressure and forces disciplined pricing or benefit changes. Elevated IBNR and conservative reserving signal persistent utilization uncertainty that can depress reported earnings and cash flow durability.
Contingent Cash Obligations (put Exposure)Material potential put liabilities create a structural capital planning risk. A large, near-term cash outflow would constrain flexibility for buybacks, M&A, or benefit relief and could force funding actions that affect long-term capital allocation and liquidity margins.
Humana News
HUM FAQ
What was Humana’s price range in the past 12 months?
Humana lowest stock price was $163.11 and its highest was $379.50 in the past 12 months.
What is Humana’s market cap?
Humana’s market cap is $45.53B.
When is Humana’s upcoming earnings report date?
Humana’s upcoming earnings report date is Jul 29, 2026 which is in 44 days.
How were Humana’s earnings last quarter?
Humana released its earnings results on Apr 29, 2026. The company reported $10.31 earnings per share for the quarter, beating the consensus estimate of $10.245 by $0.065.
Is Humana overvalued?
According to Wall Street analysts Humana’s price is currently Undervalued.
Does Humana pay dividends?
Humana pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 1.38%. See more information on Humana dividends here
What is Humana’s EPS estimate?
Humana’s EPS estimate is 7.23.
How many shares outstanding does Humana have?
Humana has 120,061,500 shares outstanding.
What happened to Humana’s price movement after its last earnings report?
Humana reported an EPS of $10.31 in its last earnings report, beating expectations of $10.245. Following the earnings report the stock price went up 5.833%.
Which hedge fund is a major shareholder of Humana?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$292.33 (42.50% Upside)
$292.33 (42.50% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 1.7%
Last 30 Days ▼ 1.7%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
63.94%
12-Months-Change
Fundamentals
Return on Equity
6.19%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Humana
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
HUM Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed constructive progress on strategic priorities — membership growth, CenterWell expansion, balance sheet improvements, operational transformation, and measured Stars progress — while candidly acknowledging persistent headwinds: medical cost trend outpacing funding, elevated early-year reserves, potential put-option cash exposure, and the need to consider benefit adjustments in 2027. Management emphasized prudence in reserving, disciplined bidding, and multiple levers (operational improvements, M&A, pricing) to meet the 2028 margin objective.View all HUM earnings summariesHUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income
HUM Stock 12 Month Forecast
Average Price Target
$292.33
▲(42.50% Upside)
Technical Analysis
Ownership Overview
0.26% Insiders
35.15% Mutual Funds
34.53% Other Institutional Investors
1.99% Public Companies and
Individual Investors